Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.

PubWeight™: 5.91‹?› | Rank: Top 1%

🔗 View Article (PMID 16354854)

Published in Chest on December 01, 2005


Marin H Kollef1, Andrew Shorr, Ying P Tabak, Vikas Gupta, Larry Z Liu, R S Johannes

Author Affiliations

1: Washington University School of Medicine, 660 South Euclid Ave, St. Louis, MO 63110, USA. mkollef@im.wustl.edu

Articles citing this

(truncated to the top 100)

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82

Hospital-acquired infections due to gram-negative bacteria. N Engl J Med (2010) 6.61

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev (2009) 5.76

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax (2009) 3.21

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med (2010) 2.15

Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun (2009) 2.11

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis (2016) 2.08

Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care (2016) 2.01

Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med (2014) 1.94

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94

Peptide signaling in the staphylococci. Chem Rev (2010) 1.89

Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest (2010) 1.76

Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis (2012) 1.55

Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration (2009) 1.54

Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration. Thromb Haemost (2013) 1.39

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care (2006) 1.37

Neutrophil depletion causes a fatal defect in murine pulmonary Staphylococcus aureus clearance. J Surg Res (2008) 1.30

Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. Antimicrob Agents Chemother (2008) 1.29

Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother (2013) 1.25

Development and validation of a disease-specific risk adjustment system using automated clinical data. Health Serv Res (2010) 1.21

Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 1.16

Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol (2012) 1.16

Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob Agents Chemother (2009) 1.13

Using electronic health record data to develop inpatient mortality predictive model: Acute Laboratory Risk of Mortality Score (ALaRMS). J Am Med Inform Assoc (2013) 1.13

Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10

Penetration of vancomycin into epithelial lining fluid in healthy volunteers. Antimicrob Agents Chemother (2011) 1.10

Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip (2011) 1.06

Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS One (2013) 1.05

Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia. Infection (2010) 1.04

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis (2013) 1.03

Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02

Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients. J Gen Intern Med (2015) 0.98

In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest (2012) 0.98

One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis (2011) 0.97

Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis (2011) 0.96

Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care (2009) 0.95

Evaluation of early mini-bronchoalveolar lavage in the diagnosis of health care-associated pneumonia: a prospective study. Crit Care (2013) 0.94

Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia. Am J Respir Crit Care Med (2015) 0.94

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. Eur J Med Res (2010) 0.94

Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia. Infect Immun (2008) 0.93

Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev (2014) 0.93

Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother (2013) 0.92

Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model. Antimicrob Agents Chemother (2012) 0.92

Heterogeneity in macrophage phagocytosis of Staphylococcus aureus strains: high-throughput scanning cytometry-based analysis. PLoS One (2009) 0.92

Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment. Am J Pathol (2009) 0.92

Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother (2014) 0.91

Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital. Tuberc Respir Dis (Seoul) (2012) 0.91

Meticillin-resistant Staphylococcus aureus and meticillin-susceptible S. aureus pneumonia: comparison of clinical and thin-section CT findings. Br J Radiol (2011) 0.90

Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective study. PLoS One (2012) 0.90

A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis (2013) 0.89

Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS One (2015) 0.89

Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med (2014) 0.88

Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia. Crit Care (2011) 0.88

Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia. Crit Care (2007) 0.88

The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study. Infect Control Hosp Epidemiol (2013) 0.88

Host airway proteins interact with Staphylococcus aureus during early pneumonia. Infect Immun (2008) 0.87

Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes. Clin Infect Dis (2016) 0.87

Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study. BMC Pulm Med (2014) 0.87

MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model. Antimicrob Agents Chemother (2015) 0.86

Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia. J Antimicrob Chemother (2015) 0.85

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia. Infect Drug Resist (2014) 0.84

Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care (2013) 0.84

Long-term medical utilization following ventilator-associated pneumonia in acute stroke and traumatic brain injury patients: a case-control study. BMC Health Serv Res (2011) 0.84

Pulmonary penetration of piperacillin and tazobactam in critically ill patients. Clin Pharmacol Ther (2014) 0.83

Health-care-associated pneumonia: a new therapeutic paradigm. Chest (2005) 0.83

Inhibited growth of Pseudomonas aeruginosa by dextran- and polyacrylic acid-coated ceria nanoparticles. Int J Nanomedicine (2013) 0.83

Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia. Clin Interv Aging (2013) 0.83

Bacteriological assessment of healthcare-associated pneumonia using a clone library analysis. PLoS One (2015) 0.83

Healthcare-associated Pneumonia and Aspiration Pneumonia. Aging Dis (2014) 0.83

CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia. J Infect Dis (2014) 0.83

Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital. Korean J Intern Med (2015) 0.82

Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. Infect Control Hosp Epidemiol (2014) 0.82

Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review. BMC Infect Dis (2015) 0.82

Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study. PLoS One (2015) 0.82

Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation. BMJ Open (2012) 0.82

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens. mSphere (2017) 0.82

Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis. Lung (2013) 0.81

Comparison of severe healthcare-associated pneumonia with severe community-acquired pneumonia. Lung (2013) 0.81

In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Antimicrob Agents Chemother (2016) 0.81

A new category--healthcare-associated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis (2006) 0.81

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials. Eur J Clin Microbiol Infect Dis (2013) 0.81

Clinical and molecular characteristics of Klebsiella pneumoniae ventilator-associated pneumonia in mainland China. BMC Infect Dis (2016) 0.80

The impact of healthcare-associated infection on mortality: failure in clinical recognition is related with inadequate antibiotic therapy. PLoS One (2013) 0.80

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy. Drug Healthc Patient Saf (2011) 0.80

Risk factors for the development of acute lung injury in patients with infectious pneumonia. Crit Care (2012) 0.80

Comparison of community-acquired, hospital-acquired, and intensive care unit-acquired acute respiratory distress syndrome: a prospective observational cohort study. Crit Care (2015) 0.80

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1). Emerg Infect Dis (2016) 0.80

Obstructing toxin pathways by targeted pore blockage. Chem Rev (2012) 0.80

Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa. J Innate Immun (2014) 0.80

Pneumonia burden in elderly patients: a classification algorithm using administrative data. BMC Infect Dis (2013) 0.79

Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia. Acad Emerg Med (2015) 0.79

Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA). Ther Clin Risk Manag (2012) 0.79

Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients? Infect Control Hosp Epidemiol (2014) 0.79

Hematopoietic but not endothelial cell MyD88 contributes to host defense during gram-negative pneumonia derived sepsis. PLoS Pathog (2014) 0.79

Healthcare-associated pneumonia: where do we go next? Clin Infect Dis (2013) 0.79

Application of a methicillin-resistant Staphylococcus aureus risk score for community-onset pneumonia patients and outcomes with initial treatment. BMC Infect Dis (2015) 0.78

Staphylococcus aureus in community-acquired pneumonia. Chest (2006) 0.78

Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4. PLoS One (2016) 0.78

Articles by these authors

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med (2012) 9.69

Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg (2009) 4.79

An automated model to identify heart failure patients at risk for 30-day readmission or death using electronic medical record data. Med Care (2010) 3.71

Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood (2011) 3.02

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol (2010) 2.99

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther (2006) 2.86

The early prediction of mortality in acute pancreatitis: a large population-based study. Gut (2008) 2.59

Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med (2006) 2.51

A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc (2011) 2.37

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood (2008) 2.35

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood (2008) 2.34

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol (2010) 2.31

A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci (1989) 2.08

Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med (2009) 1.93

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant (2011) 1.88

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood (2012) 1.86

Medication adherence: a call for action. Am Heart J (2011) 1.85

Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest (2006) 1.84

tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration. Development (2011) 1.83

A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies. Clin Cancer Res (2008) 1.77

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol (2011) 1.74

Comparison of cosmetic outcome between single-incision laparoscopic cholecystectomy and conventional laparoscopic cholecystectomy: an objective study. J Laparoendosc Adv Surg Tech A (2011) 1.73

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. J Clin Oncol (2013) 1.70

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years). Leuk Lymphoma (2007) 1.70

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplant (2010) 1.69

Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant (2009) 1.68

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I. Haematologica (2013) 1.67

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. Ann Pharmacother (2006) 1.56

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood (2010) 1.50

Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc (2001) 1.49

Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia (2010) 1.45

Variation in lung cancer risk by smoky coal subtype in Xuanwei, China. Int J Cancer (2008) 1.45

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood (2008) 1.42

Superstition but not distrust in the medical system predicts the use of complementary and alternative medicine in a group of patients with acute leukemia. Leuk Lymphoma (2008) 1.42

Proteome reference maps of the Lotus japonicus nodule and root. Proteomics (2014) 1.39

Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts. Eur J Haematol (2014) 1.39

Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol (2007) 1.39

Effects of the ritonavir price increase on the cost of protease inhibitor regimens in United States. Manag Care Interface (2006) 1.38

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care (2006) 1.37

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood (2011) 1.33

Surgical site infections: Causative pathogens and associated outcomes. Am J Infect Control (2009) 1.28

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant (2009) 1.28

Translational profiling of cardiomyocytes identifies an early Jak1/Stat3 injury response required for zebrafish heart regeneration. Proc Natl Acad Sci U S A (2013) 1.27

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood (2009) 1.25

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2010) 1.25

The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav (2007) 1.23

Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. Br J Haematol (2009) 1.22

Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care (2011) 1.18

Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology (1989) 1.17

Adverse outcomes from hospital-acquired infection in Pennsylvania cannot be attributed to increased risk on admission. Am J Med Qual (2006) 1.16

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biol Blood Marrow Transplant (2010) 1.15

The efficacy of a novel approach to transversus abdominis plane block for postoperative analgesia after colorectal surgery. Anesth Analg (2011) 1.14

The quality of gastroenterological reports based on free text dictation: an evaluation in endoscopy and ultrasonography. Endoscopy (1991) 1.14

Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J (2009) 1.13

Prescription-writing with a PC. Comput Methods Programs Biomed (1986) 1.12

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant (2010) 1.11

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. Br J Haematol (2009) 1.07

Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant (2010) 1.06

Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant (2007) 1.06

Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis. Expert Opin Pharmacother (2012) 1.06

Pancreatic cyst fluid analysis--a review. J Gastrointestin Liver Dis (2011) 1.05

Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol (2011) 1.05

The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol (2006) 1.04

Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol (2009) 1.04

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood (2012) 1.03

The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults. Crit Rev Oncol Hematol (2007) 1.02

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 1.01

Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med (2009) 1.01

The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) (2012) 1.01

A novel bacterial blight resistance gene from Oryza nivara mapped to 38 kb region on chromosome 4L and transferred to Oryza sativa L. Genet Res (Camb) (2008) 1.01

Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation. Cancer (2008) 0.99

Spontaneous hemorrhage of a facial neurofibroma: endovascular embolization before surgical intervention. J Craniofac Surg (2013) 0.99

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica (2013) 0.97

Determining initial and follow-up costs of cardiovascular events in a US managed care population. BMC Cardiovasc Disord (2011) 0.97

Surgical management and outcome of tuberculous atlantoaxial dislocation: a 15-year experience. Neurosurgery (2003) 0.96

Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol (2010) 0.96

Generic and therapeutic statin switches and disruptions in therapy. Curr Med Res Opin (2009) 0.96

A prospective controlled trial comparing single-incision and conventional laparoscopic cholecystectomy: caution before damage control. Surg Laparosc Endosc Percutan Tech (2012) 0.95

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Am J Hematol (2014) 0.95

Effect of physician tutorials on prescribing patterns of graduate physicians. J Med Educ (1981) 0.95

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis. Br J Haematol (2013) 0.95

A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients. Clin Ther (2007) 0.95

Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care (2009) 0.95

Therapeutic dose assessment of patient switching from atorvastatin to simvastatin. Am J Manag Care (2007) 0.94

Isolated tuberculous abscess in biceps brachii muscle of a young male. J Infect (2002) 0.94

Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia. Crit Rev Oncol Hematol (2008) 0.94

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy. Am J Hematol (2008) 0.94

Diffusion tensor imaging in late posttraumatic epilepsy. Epilepsia (2005) 0.93

Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy. Br J Haematol (2008) 0.93

Fistulization in the GI tract in acute pancreatitis. Gastrointest Endosc (2011) 0.93

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Haematologica (2012) 0.93

Ollier's disease: characteristic Tc-99m MDP scan features. Clin Nucl Med (2003) 0.92